Efficacy and Safety of Belimumab for Prevention of Disease Flares in SLE Patients With Low Disease Activity
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 27 Sep 2021 Status changed from not yet recruiting to recruiting.
- 08 Mar 2021 Planned initiation date changed from 1 Nov 2020 to 15 Mar 2021.
- 18 Aug 2020 New trial record